Efavirenz: uses, dosage, safety, and treatment guidance

Efavirenz is a non-nucleoside reverse transcriptase inhibitor antiretroviral used to treat HIV-1 infection as one component of a complete combination antiretroviral regimen. The active ingredient is efavirenz, marketed in various regions under Sustiva, Stocrin, and generic efavirenz; it is also included in fixed-dose HIV combinations.

• Indications: HIV-1 treatment in adults and eligible children in combination with other active antiretrovirals; it is not used alone because resistance develops rapidly.
• Dosage: usually taken once daily, with weight-based pediatric dosing and selection based on the complete regimen, resistance, liver function, neuropsychiatric effects, and interactions.
• Contraindications: hypersensitivity, concomitant elbasvir-grazoprevir, or use with medicines whose concentrations become dangerously altered; severe liver disease and pregnancy planning require specialist review.

What is Efavirenz used for?

Efavirenz is prescribed for carefully selected patients when its expected clinical benefit outweighs its condition-specific risks.

HIV-1 treatment in adults and eligible children in combination with other active antiretrovirals; it is not used alone because resistance develops rapidly. Diagnosis matters because similar symptoms can arise from conditions that need different treatment. A prescriber considers medical history, current medicines, examination findings, laboratory data, and treatment goals before choosing this drug.

How does Efavirenz work?

It binds a hydrophobic pocket near HIV-1 reverse transcriptase and allosterically inhibits the enzyme, blocking conversion of viral RNA into DNA. It does not require intracellular phosphorylation and must be combined with other antiretrovirals.

The pharmacologic effect does not make the medicine suitable for every person with similar symptoms. Patients who plan to buy Efavirenz should verify the diagnosis and prescription first, because Efavirenz price cannot substitute for clinical selection, monitoring, or authentic supply.

How should Efavirenz be taken or used?

Take consistently on an empty stomach, preferably at bedtime during early therapy to reduce daytime nervous-system effects, unless the regimen label differs. Swallow whole or use approved capsule-sprinkle instructions. Never stop or change one HIV medicine independently.

Read the dispensing label every time, use the correct measuring or administration device, and never share prescription medicine. Contact the care team before changing the schedule, crushing a dosage form, switching formulations, or stopping long-term therapy.

Which Efavirenz dosage variants are available?

Common marketed variants include 50 mg, 100 mg, 200 mg, and 600 mg capsules or tablets; and 200 mg dispersible tablets in selected markets.

Availability and licensed indications differ by country and manufacturer. When comparing where to buy Efavirenz 50 mg, 100 mg, 200 mg, and 600 mg capsules or tablets; and 200 mg dispersible tablets in selected markets, confirm the precise strength, dosage form, route, and package directions rather than choosing by Efavirenz price alone. Products with different release characteristics, concentrations, or routes may not be interchangeable.

What are the most common side effects of Efavirenz?

The more frequently reported effects include dizziness, vivid dreams, insomnia, drowsiness, impaired concentration, rash, nausea, headache, and fatigue.

Not every patient experiences these reactions, and their likelihood depends on dose, formulation, duration, health status, and other medicines. Record when symptoms begin and whether they follow a dose. Persistent, worsening, or function-limiting effects should be discussed rather than managed by an unapproved dose change.

Which serious effects require urgent medical care?

Severe depression, suicidal thoughts, hallucinations, psychosis, seizure, blistering rash, jaundice, fainting, or irregular heartbeat requires urgent care. Persistent neuropsychiatric effects, severe skin reactions, liver injury, and QT prolongation can occur.

Emergency warning signs should not be watched at home while waiting for the next routine appointment. Bring the medication package and a current medicine list when seeking urgent help so clinicians can identify the active ingredient, strength, and possible interaction.

Which medicines and substances interact with Efavirenz?

Efavirenz induces and inhibits several CYP enzymes, affecting many antivirals, contraceptives, anticonvulsants, anticoagulants, methadone, statins, and transplant medicines. Rifampin may alter dosing; St John’s wort can reduce exposure, and voriconazole requires a special regimen or avoidance.

Give the prescriber and pharmacist a complete list of prescription drugs, nonprescription products, vitamins, supplements, and recreational substances. Interaction risk can arise when another drug is started, stopped, or dose-adjusted, even after a stable period on treatment.

Can Efavirenz be used with alcohol?

Alcohol advice depends on the indication, formulation, organ function, and other medicines, so an individualized recommendation is safer than assuming that moderate use is harmless.

Alcohol may worsen dizziness, sedation, dehydration, low blood pressure, impaired glucose control, gastrointestinal irritation, or liver stress where those effects are relevant. Avoid alcohol when the prescriber or product information advises it, and never drive when treatment or alcohol impairs alertness.

Is Efavirenz safe during pregnancy or breastfeeding?

Current HIV guidance may permit efavirenz during pregnancy when it is the effective regimen, despite earlier concerns; specialist counseling should consider viral suppression and alternatives. Breastfeeding recommendations depend on HIV guidance and local resources.

Tell the prescriber about pregnancy plans, a positive test, breastfeeding, or fertility concerns before treatment whenever possible. Exposure decisions should consider gestational timing, dose, route, untreated disease, safer alternatives, and infant factors.

What monitoring is needed during Efavirenz treatment?

Monitor HIV viral load, CD4 count, adherence, resistance, liver tests, lipids, mood, sleep, cognition, rash, pregnancy plans, and interactions. A positive urine cannabinoid screening result can be false and should be confirmed specifically.

Keep scheduled reviews and report new symptoms between visits. Monitoring is intended to detect loss of effectiveness, organ toxicity, interaction effects, and the need for dose adjustment before a preventable complication becomes severe.

What should be done after a missed dose or overdose?

Take a missed dose when remembered unless the next is near and never double. Overdose can intensify nervous-system symptoms, involuntary movements, abnormal rhythm, or liver effects and needs poison-center or HIV-clinic guidance.

Do not induce vomiting or improvise a corrective dose. Exact advice depends on the amount, time, formulation, symptoms, age, and medical history, so provide those details promptly to a poison center or emergency clinician.

How should Efavirenz be stored and obtained?

Store tablets or capsules at labeled room temperature away from moisture and heat. Keep fixed-dose combinations clearly identified and retain original packaging.

Before deciding to buy Efavirenz, confirm the authorized dosage form, intact packaging, expiration date, and required monitoring. Efavirenz price should remain secondary to prescription accuracy, storage integrity, and licensed dispensing.

People who buy Efavirenz should use a licensed pharmacy and contact a qualified clinician if the supplied product differs from the prescription or expected appearance.

Medical information disclaimer

This page provides general education and does not replace diagnosis, prescribing, monitoring, or emergency care. Follow the instructions supplied by the treating clinician and the medicine’s approved local labeling.